We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Praxis Precision Medicines Inc | NASDAQ:PRAX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.78 | -4.17% | 40.775 | 40.73 | 41.50 | 43.33 | 39.57 | 42.53 | 144,408 | 16:15:14 |
|
PRAXIS PRECISION
MEDICINES, INC. |
| |
|
|
| | |
Per share
|
| |
Per Pre-funded
Warrant |
| |
Total
|
| |||||||||
Public offering price | | | | $ | 35.50 | | | | | $ | 35.499900 | | | | | $ | 149,987,394.33 | | |
Underwriting discounts and commissions (1) | | | | $ | 2.13 | | | | | $ | 2.129994 | | | | | $ | 8,999,243.66 | | |
Proceeds to Praxis Precision Medicines, Inc. before expenses
|
| | | $ | 33.37 | | | | | $ | 33.369906 | | | | | $ | 140,988,150.67 | | |
| PROSPECTUS SUPPLEMENT | | | |||||
| | | | | S-ii | | | |
| | | | | S-1 | | | |
| | | | | S-3 | | | |
| | | | | S-5 | | | |
| | | | | S-7 | | | |
| | | | | S-9 | | | |
| | | | | S-10 | | | |
| | | | | S-11 | | | |
| | | | | S-13 | | | |
| | | | | S-15 | | | |
| | | | | S-21 | | | |
| | | | | S-29 | | | |
| | | | | S-29 | | | |
| | | | | S-29 | | | |
| ACCOMPANYING PROSPECTUS | | | |||||
| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 12 | | | |
| | | | | 19 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | |
|
Public offering price per share
|
| | | | | | | | | $ | 35.50 | | |
|
Net tangible book value per share as of September 30, 2023
|
| | | $ | 10.12 | | | | | | | | |
|
Increase in as adjusted net tangible book value per share attributable to this offering
|
| | | $ | 7.64 | | | | | | | | |
|
As adjusted net tangible book value per share after this offering
|
| | | | | | | | | | 17.76 | | |
|
Dilution per share to new investors participating in this offering
|
| | | | | | | | | $ | 17.74 | | |
Underwriter
|
| |
Number
of Shares |
| |
Number of
Pre-Funded Warrants |
| ||||||
Piper Sandler & Co.
|
| | | | 2,376,206 | | | | | | 792,544 | | |
Truist Securities, Inc.
|
| | | | 633,655 | | | | | | 211,345 | | |
H.C. Wainwright & Co., LLC
|
| | | | 158,414 | | | | | | 52,836 | | |
Total
|
| | | | 3,168,275 | | | | | | 1,056,725 | | |
| | |
Per Share
|
| |
Per
Pre-Funded Warrant |
| |
Total
Without Option Exercise |
| |
Total
With Full Option Exercise |
| ||||||||||||
Public offering price
|
| | | $ | 35.50 | | | | | $ | 35.499900 | | | | | $ | 149,987,394.33 | | | | | $ | 172,485,519.33 | | |
Underwriting discount and commissions
|
| | | $ | 2.13 | | | | | $ | 2.129994 | | | | | $ | 8,999,243.66 | | | | | $ | 10,349,131.16 | | |
Proceeds, before expenses, to us
|
| | | $ | 33.37 | | | | | $ | 33.369906 | | | | | $ | 140,988,150.67 | | | | | $ | 162,136,388.17 | | |
| | | | | 1 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 12 | | | |
| | | | | 19 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | |
1 Year Praxis Precision Medicines Chart |
1 Month Praxis Precision Medicines Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions